{
  "meta": {
    "title": "Community_Ophthalmology_Miscellaneous",
    "url": "https://brainandscalpel.vercel.app/community-ophthalmology-miscellaneous-6996d0a3.html",
    "scrapedAt": "2025-11-29T18:31:10.353Z"
  },
  "questions": [
    {
      "id": 18484,
      "choices": [
        {
          "id": 73894,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-2, c-3, d-4</span></p>"
        },
        {
          "id": 73895,
          "text": "<p><span style=\"font-size:12.0pt;\">a-3, b-1, c-4, d-2</span></p>"
        },
        {
          "id": 73896,
          "text": "<p><span style=\"font-size:12.0pt;\">a-3, b-4, c-1, d-2</span></p>"
        },
        {
          "id": 73897,
          "text": "<p><span style=\"font-size:12.0pt;\">a-4, b-1, c-2, d-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following :</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-112842.jpeg\" alt=\"\" width=\"700\" height=\"168\"></p><p>&nbsp;</p>",
      "unique_key": "Q4139860",
      "question_audio": null,
      "question_video": null,
      "map_id": 18255,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) a</strong>-<strong>3, b</strong>-<strong>1, c</strong>-<strong>4, d</strong>-<strong>2</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-112852.jpeg\" alt=\"\" width=\"700\" height=\"196\"></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: 476/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73895,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18465,
      "choices": [
        {
          "id": 73818,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&lt; 12 hours</span></span></span></p>"
        },
        {
          "id": 73819,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&lt;30 minutes</span></span></span></p>"
        },
        {
          "id": 73820,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&lt;6 hours</span></span></span></p>"
        },
        {
          "id": 73821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">24 hours</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the ideal time between time of death &amp; retrieval of eyes for eye donation?</span></span></span></p>",
      "unique_key": "Q6477409",
      "question_audio": null,
      "question_video": null,
      "map_id": 18235,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) &lt;6 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>eyes have to be removed</strong> within <strong>6 hours of death</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 488/&nbsp; systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18476,
      "choices": [
        {
          "id": 73862,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unites States of America</span></span></span></p>"
        },
        {
          "id": 73863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">China</span></span></span></p>"
        },
        {
          "id": 73864,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">India</span></span></span></p>"
        },
        {
          "id": 73865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">South Africa</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following is the first country to establish a blindness control programme for the nation?</span></span></span></p>",
      "unique_key": "Q7922897",
      "question_audio": null,
      "question_video": null,
      "map_id": 18246,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) India</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">India was the first country&nbsp;</span></strong><span style=\"font-size:12.0pt\">in the world to launch the <strong>National Programme for Control of Blindness</strong> (NPCB) in the year <strong>1976</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Pg 480/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18479,
      "choices": [
        {
          "id": 73874,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Refractive error</span></span></span></p>"
        },
        {
          "id": 73875,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glaucoma</span></span></span></p>"
        },
        {
          "id": 73876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trachoma</span></span></span></p>"
        },
        {
          "id": 73877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cataract</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following is the most common cause of blindness according to NPCB?</span></span></span></p>",
      "unique_key": "Q9527152",
      "question_audio": null,
      "question_video": null,
      "map_id": 18249,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Cataract</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cataract&nbsp;</span></strong><span style=\"font-size:12.0pt\">continues to be the <strong>single largest cause of blindness in india</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Main causes of blindness: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cataract (62.6%) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Refractive Error (19.70%) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Corneal Blindness (0.90%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glaucoma (5.80%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical Complication (1.20%) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Posterior Capsular Opacification (0.90%) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Posterior Segment Disorder (4.70%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Others (4.19%)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cataract&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the <strong>commonest cause of blindness in India</strong> according to <strong>NPCB</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 483/&nbsp; systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18463,
      "choices": [
        {
          "id": 73810,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Retrieve and store donor eyes</span></p>"
        },
        {
          "id": 73811,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Evaluate and distribute eye tissue for transplantation</span></p>"
        },
        {
          "id": 73812,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Use donor eyes for research and education</span></p>"
        },
        {
          "id": 73813,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the function of an Eye Bank?</span></p>",
      "unique_key": "Q5623562",
      "question_audio": null,
      "question_video": null,
      "map_id": 18233,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) All of the above</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Promotion&nbsp;</strong>of eye donation.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Registration&nbsp;</strong>&amp; <strong>collection</strong> of donated eyes.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Receiving&nbsp;</strong>&amp; <strong>preservation</strong> of donor eyes.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Distribution&nbsp;</strong>&amp; <strong>research</strong> activities.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: pg 487/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18464,
      "choices": [
        {
          "id": 73814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cornea only</span></span></span></p>"
        },
        {
          "id": 73815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cornea along with 3mm of adjacent sclera</span></span></span></p>"
        },
        {
          "id": 73816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Whole eye ball with a portion of the optic nerve</span></span></span></p>"
        },
        {
          "id": 73817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Whole eye ball along with surrounding orbital fat, muscles and nerves</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enucleation for donor eye retrieval involves gathering which all components?</span></span></span></p>",
      "unique_key": "Q3536954",
      "question_audio": null,
      "question_video": null,
      "map_id": 18234,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Whole eye ball with a portion of the optic nerve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tissue retrieval&nbsp;</span></strong><span style=\"font-size:12.0pt\">by <strong>enucleation</strong> from <strong>cadavers includes removal of the entire eye ball</strong> along with a <strong>portion of the optic nerve</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 308/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18468,
      "choices": [
        {
          "id": 73830,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HIV</span></span></span></p>"
        },
        {
          "id": 73831,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral hepaitits</span></span></span></p>"
        },
        {
          "id": 73832,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syphilis</span></span></span></p>"
        },
        {
          "id": 73833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is a contraindication for eye donation?</span></span></span></p>",
      "unique_key": "Q1402275",
      "question_audio": null,
      "question_video": null,
      "map_id": 18238,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CONTRAINDICATIONS for eye donation</span></strong><span style=\"font-size:12.0pt\"> include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Death&nbsp;</span></strong><span style=\"font-size:12.0pt\">from <strong>unknown cause</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Infections&nbsp;</span></strong><span style=\"font-size:12.0pt\">like: <strong>HIV, Syphilis, TB, congenital rubella, viral hepatitis</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Creutzfeldt Jacob disease</span></strong><span style=\"font-size:12.0pt\">, SSPE etc.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Recipient of transplanted organ</span></strong><span style=\"font-size:12.0pt\">, etc</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 241/ corneal &amp; refractive surgery/ Kanski&rsquo;s clinical ophthalmology 8<sup>th</sup> edition.</span></strong></span></span></p>",
      "correct_choice_id": 73833,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18469,
      "choices": [
        {
          "id": 73834,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Eyes can be removed from a living human being with consent.</span></p>"
        },
        {
          "id": 73835,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Optic atrophy in recipient is a contraindication</span></p>"
        },
        {
          "id": 73836,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rabies is a contraindication.</span></p>"
        },
        {
          "id": 73837,
          "text": "<p><span style=\"font-size:12.0pt;\">Donated eyes can never be sold or bought.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not true regarding eye donation?</span></p>",
      "unique_key": "Q6467217",
      "question_audio": null,
      "question_video": null,
      "map_id": 18239,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Eyes can be removed from a living human being with consent.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Anyone of any age&nbsp;</strong>can <strong>pledge to donate eyes after death</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Donated eyes&nbsp;</strong>can <strong>never be bought</strong> or sold.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Eyes CANNOT be removed from a living human being&nbsp;</strong>inspite of his/her consent &amp; wish.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Contraindications for eye donation include <strong>transmissible diseases like</strong> â€“ <strong>HIV, HBsAg, syphilis, TB</strong> etc.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Recipients with only anterior segment diseases are eligible for corneal transplantation, and should have a normal posterior segment.&nbsp;</span></p></li></ul>",
      "correct_choice_id": 73834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18470,
      "choices": [
        {
          "id": 73838,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Corneal epithelial scraping</span></span></span></p>"
        },
        {
          "id": 73839,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood</span></span></span></p>"
        },
        {
          "id": 73840,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitreous sample</span></span></span></p>"
        },
        {
          "id": 73841,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scleral biopsy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the sample used for the screening of HIV, Syphilis, HBsAg and Anti-HCV in an eye donor? </span></span></span></p>",
      "unique_key": "Q6003961",
      "question_audio": null,
      "question_video": null,
      "map_id": 18240,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Blood</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">At the <strong>time of eye retrieval</strong> , <strong>blood sample is collected from the cadaver</strong> and sent for <strong>screening infections</strong> like- HIV, HBsAg, Syphilis etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Pg 560/ Eye banking/ PEYMAN&rsquo;S principle &amp; practise of ophthalmology/ 2<sup>nd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73839,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18473,
      "choices": [
        {
          "id": 73850,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">MK medium</span></p>"
        },
        {
          "id": 73851,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Moist chamber storage</span></p>"
        },
        {
          "id": 73852,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cryopreservation</span></p>"
        },
        {
          "id": 73853,
          "text": "<p><span style=\"font-size:12.0pt;\">Organ culture method</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following is a method of short-term storage after eye ball retrieval?</span></p>",
      "unique_key": "Q6412702",
      "question_audio": null,
      "question_video": null,
      "map_id": 18243,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Moist chamber storage</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Whole globe&nbsp;</strong>is <strong>sealed in a container and stored at 4 degree C</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Short-term&nbsp;</strong>(upto 48 hours) = <strong>Moist chamber storage</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/picture20_SOwohaw.jpg\" alt=\"\" width=\"300\" height=\"360\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Intermediate&nbsp;</strong>(2 weeks) = <strong>MK medium, optisol</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Long-term&nbsp;</strong>(35 days) = <strong>Organ culture method, cryopreservation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>MK Medium (McCarey-Kaufman Medium)</strong>: This is a <strong>medium used for the storage of corneal tissues</strong>. However, <strong>MK medium is typically used for short-term preservation</strong> of <strong>up to 4 days</strong>. It's often used in scenarios where <strong>corneal transplantation is planned shortly </strong>after <strong>retrieval</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/picture21_SCH4LXc.jpg\" alt=\"\" width=\"300\" height=\"225\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Cryopreservation</strong>: This <strong>method involves freezing the tissue for long-term storage</strong>. Cryopreservation is <strong>not commonly used for corneal storage</strong> due to the risk of damaging the corneal endothelial cells during the freeze-thaw process.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Organ Culture Method</strong>: This is a <strong>method used for longer-term storage of corneal tissues</strong>, allowing <strong>storage for up to 4 weeks</strong>. It involves <strong>keeping the cornea in a special nutrient medium</strong> at a <strong>controlled temperature,</strong> which is higher than that used in MK medium or moist chamber storage.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>Moist chamber storage</strong> is a method used for the <strong>short-term storage of corneal tissue</strong> after <strong>eyeball retrieval</strong>, suitable for maintaining the <strong>viability of the cornea for up to 24-48 hours</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: pg 137/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73851,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18475,
      "choices": [
        {
          "id": 73858,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Res muthiah</span></span></span></p>"
        },
        {
          "id": 73859,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sushrutha</span></span></span></p>"
        },
        {
          "id": 73860,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Govinda pavenkataswamy</span></span></span></p>"
        },
        {
          "id": 73861,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sir Harold ridley</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Who established the first eye bank in India?</span></span></span></p>",
      "unique_key": "Q8098547",
      "question_audio": null,
      "question_video": null,
      "map_id": 18245,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Res muthiah</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>first eye bank establishment</strong> and <strong>1<sup>st</sup> cornea transplantation</strong> in <strong>INDIA</strong> was done by <strong>late DR. RES MUTHIAH</strong> in the <strong>year 1948.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: </span></strong><span style=\"font-size:12.0pt\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/10643183\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://pubmed.ncbi.nlm.nih.gov/10643183</strong></a></span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 73858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18477,
      "choices": [
        {
          "id": 73866,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1976</span></span></span></p>"
        },
        {
          "id": 73867,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1986</span></span></span></p>"
        },
        {
          "id": 73868,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1966</span></span></span></p>"
        },
        {
          "id": 73869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1996</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When was NPCB established in India?</span></span></span></p>",
      "unique_key": "Q8811302",
      "question_audio": null,
      "question_video": null,
      "map_id": 18247,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 1976</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation</span></strong></span></span></u></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>National Programme for Control of Blindness</strong> (NPCB) was launched in <strong>India in 1976 with the goal of reducing the prevalence of blindness</strong> through comprehensive eye care services and improving accessibility to eye care facilities across the country. <strong>This program has been pivotal in addressing various eye-related issues</strong> and enhancing the quality of life for many individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key aspects of the National Programme for Control of Blindness (NPCB) include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Focus on Preventable Blindness</strong>: A significant emphasis is placed on preventing blindness caused by conditions that are easily treatable, such as cataract, which is the leading cause of blindness in India.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Community Participation:</strong> The program encourages community involvement and utilizes a decentralized approach, engaging primary health centers and local healthcare workers to maximize its outreach and impact.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Capacity Building:</strong> It aims to strengthen the infrastructure for eye care services by upgrading existing facilities, providing training to eye care professionals, and increasing the availability of specialized equipment and materials.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Partnerships</strong>: The NPCB collaborates with various governmental and non-governmental organizations, including international agencies, to pool resources, share expertise, and expand its reach and effectiveness.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Monitoring and Evaluation</strong>: Regular monitoring and evaluation mechanisms are in place to assess the program&#39;s performance, identify areas for improvement, and ensure the achievement of its targets.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Pg 480/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73866,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18478,
      "choices": [
        {
          "id": 73870,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/60</span></span></span></p>"
        },
        {
          "id": 73871,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3/60</span></span></span></p>"
        },
        {
          "id": 73872,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/18</span></span></span></p>"
        },
        {
          "id": 73873,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1/60</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to NPCB,a visual acuity below which of the following levels is classified as blindness?</span></span></span></p>",
      "unique_key": "Q1699157",
      "question_audio": null,
      "question_video": null,
      "map_id": 18248,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 3/60</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">NPCB definition of blindness:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Presenting visual acuity &lt; 3/60&nbsp;</span></strong><span style=\"font-size:12.0pt\">or <strong>counting fingers at 3 metres</strong> or <strong>central visual field</strong> less than <strong>10 degree in better eye</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Old definition: Visual acuity less than 6/60 or central field less than 20 degree in better eye.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 476/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73871,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18481,
      "choices": [
        {
          "id": 73882,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/18</span></span></span></p>"
        },
        {
          "id": 73883,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/60</span></span></span></p>"
        },
        {
          "id": 73884,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3/60</span></span></span></p>"
        },
        {
          "id": 73885,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/24</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the visual acuity below which it is termed as low vision according to WHO?</span></span></span></p>",
      "unique_key": "Q1905459",
      "question_audio": null,
      "question_video": null,
      "map_id": 18251,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 6/18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to <strong>WHO</strong>, a <strong>visual acuity of &lt;6/18 to 3/60 in the better eye</strong> is defined <strong>as low vision</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Page no. 444/ Chapter 20/ Community Ophthalmology/ Ed. 4/ AK Khurana Comprehensive ophthalmology</span></strong></span></span></p>",
      "correct_choice_id": 73882,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18483,
      "choices": [
        {
          "id": 73890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6/60</span></span></span></p>"
        },
        {
          "id": 73891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3/60</span></span></span></p>"
        },
        {
          "id": 73892,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1/60</span></span></span></p>"
        },
        {
          "id": 73893,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5/60</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to WHO, a visual acuity of less than what value is defined as a criterion for blindness?</span></span></span></p>",
      "unique_key": "Q4106439",
      "question_audio": null,
      "question_video": null,
      "map_id": 18252,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans. B)</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>3/60</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO&nbsp;</span></strong><span style=\"font-size:12.0pt\">in <strong>1972</strong> proposed a <strong>uniform criterion</strong>. &ldquo;<strong>Visual acuity of less than 3/60</strong> (Snellen) or <strong>its equivalent</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 475/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18485,
      "choices": [
        {
          "id": 73898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cataract</span></span></span></p>"
        },
        {
          "id": 73899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glaucoma</span></span></span></p>"
        },
        {
          "id": 73900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trachoma</span></span></span></p>"
        },
        {
          "id": 73901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onchocerciasis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The following are the major blinding eye conditions for immediate attention to achieve the goals of VISION 2020, by WHO, except?</span></span></span></p>",
      "unique_key": "Q1584758",
      "question_audio": null,
      "question_video": null,
      "map_id": 18256,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Glaucoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO&nbsp;</span></strong><span style=\"font-size:12.0pt\">identified <strong>5 major blinding eye condition</strong> for immediate action:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cataract</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Childhood blindness</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Trachoma</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Refractive errors</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oncocerchiasis</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Glaucoma&nbsp;</span></strong><span style=\"font-size:12.0pt\">is <strong>not one of the primary goals of Vision 2020 initiative</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 478/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pizzarello L,&nbsp;Abiose A,&nbsp;Ffytche T, et al. VISION 2020: The Right to Sight:&nbsp;A Global Initiative to Eliminate Avoidable Blindness.&nbsp;<em>Arch Ophthalmol.</em>&nbsp;2004;122(4):615&ndash;620. doi:10.1001/archopht.122.4.615</span></strong></span></span></p>",
      "correct_choice_id": 73899,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18488,
      "choices": [
        {
          "id": 73910,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A deficiency</span></p>"
        },
        {
          "id": 73911,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital cataract</span></p>"
        },
        {
          "id": 73912,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinopathy of prematurity</span></p>"
        },
        {
          "id": 73913,
          "text": "<p><span style=\"font-size:12.0pt;\">Refractive errors</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the commonest cause of blindness in children?</span></p>",
      "unique_key": "Q4506772",
      "question_audio": null,
      "question_video": null,
      "map_id": 18259,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Congenital cataract</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Refractive error would cause vision impairment not blindness</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cataract would cause blindness</strong></span><br>&nbsp;</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Refractive errors&nbsp;</strong>are the <strong>commonest cause of visual impairment</strong> in <strong>children</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Others:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Vitamin A deficiency</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Measles</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Congenital cataract</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Retinopathy of prematurity</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Childhood glaucoma</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Vitamin A Deficiency</strong>: This used to be <strong>one of the leading causes of preventable blindness in children</strong>, especially in <strong>developing countries</strong>. Vitamin A deficiency can lead to <strong>xerophthalmia and keratomalacia</strong>, resulting in <strong>severe visual impairment</strong> or blindness. However, with improved nutrition and supplementation programs, its prevalence has significantly decreased in many parts of the world.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Congenital Cataract</strong>: This is a <strong>significant cause of visual impairment</strong> and <strong>treatable blindness in children</strong>. Congenital cataracts can be <strong>isolated or part of systemic syndromes</strong>, and <strong>early detection</strong> and <strong>surgical intervention</strong> are crucial for visual development.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Retinopathy of Prematurity (ROP)</strong>: ROP is a disease of the eye <strong>affecting prematurely born babies</strong>. It's related to the <strong>use of supplemental oxygen in the neonatal period</strong>. ROP can lead to blindness but is preventable with proper screening and timely treatment.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">While <strong>vitamin A deficiency, congenital cataract, and retinopathy of prematurity are significant causes of childhood blindness</strong>, <strong>refractive errors</strong> are <strong>currently</strong> recognized as the <strong>most common cause of visual impairment</strong> in children due to their high prevalence and frequent lack of correction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: pg 483/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18489,
      "choices": [
        {
          "id": 73914,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">35</span></span></span></p>"
        },
        {
          "id": 73915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">45</span></span></span></p>"
        },
        {
          "id": 73916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">55</span></span></span></p>"
        },
        {
          "id": 73917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">60</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the strategic plan for VISION 2020, glaucoma screening is done for all persons above the age of:</span></span></span></p>",
      "unique_key": "Q2397433",
      "question_audio": null,
      "question_video": null,
      "map_id": 18260,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 35</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">VISION 2020&nbsp;</span></strong><span style=\"font-size:12.0pt\">recommends <strong>opportunistic glaucoma screening</strong> at <strong>eye care institutions</strong> in all persons </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Above the age of 35 </span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Those with <strong>diabetes mellitus</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Family history of <strong>glaucoma</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 484/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition </span></strong></span></span></p>",
      "correct_choice_id": 73914,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18491,
      "choices": [
        {
          "id": 73922,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">August 25 to September 8</span></span></span></p>"
        },
        {
          "id": 73923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">January 1 to january 15</span></span></span></p>"
        },
        {
          "id": 73924,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">October 25 to November 8</span></span></span></p>"
        },
        {
          "id": 73925,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">April 25 to May 8</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Annually, when is the eye donation fortnight organised?</span></span></span></p>",
      "unique_key": "Q7371719",
      "question_audio": null,
      "question_video": null,
      "map_id": 18261,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) August 25 to September 8</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Under <strong>NPCB</strong>, <strong>eye donation fortnight</strong> is organised from <strong>25<sup>th</sup> August to 8<sup>th</sup> September every year</strong> to promote eye donation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\">Ref: pg 485/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></em></strong></span></span></p>",
      "correct_choice_id": 73922,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18492,
      "choices": [
        {
          "id": 73926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&gt;200</span></span></span></p>"
        },
        {
          "id": 73927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&gt;50</span></span></span></p>"
        },
        {
          "id": 73928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&gt;75</span></span></span></p>"
        },
        {
          "id": 73929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&gt;100</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An operating eye surgeon should not perform more than how many surgeries in a day at an eye camp according to VISION 2020?</span></span></span></p>",
      "unique_key": "Q8243862",
      "question_audio": null,
      "question_video": null,
      "map_id": 18262,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) &gt;50</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ideally the number of operations&nbsp;</span></strong><span style=\"font-size:12.0pt\">performed <strong>per day by a surgeon</strong> should <strong>not exceed 50</strong> and in a <strong>camp should not exceed 200</strong> to maintain quality of surgery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 487 / systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18493,
      "choices": [
        {
          "id": 73930,
          "text": "<p><span style=\"font-size:12.0pt;\">Presently SICS &amp; phacoemulsification techniques are recommended</span></p>"
        },
        {
          "id": 73931,
          "text": "<p><span style=\"font-size:12.0pt;\">At least 5 operating surgeons should be present</span></p>"
        },
        {
          "id": 73932,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the eyes should never be operated at one go</span></p>"
        },
        {
          "id": 73933,
          "text": "<p><span style=\"font-size:12.0pt;\">Cases with surgical risks such as diabetes, hypertensives &amp; cardiac problems should not be operated in camps</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false regarding the guidelines laid down by the government of India for organising eye camps?</span></p>",
      "unique_key": "Q6428643",
      "question_audio": null,
      "question_video": null,
      "map_id": 18263,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">&nbsp;<strong>Ans. B) At least 5 operating surgeons should be present</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">At <strong>least 1</strong>, <strong>preferably 2 operating surgeons</strong> should <strong>perform cataract surgeries</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Presently both <strong>SICS &amp; PHACOEMULSIFICATION techniques are performed</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Both eyes should never be operated at one go</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cases with associated risk factors should be referred to base hospitals.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Presently SICS &amp; Phacoemulsification Techniques are Recommended</strong>: <strong>Small Incision Cataract Surgery</strong> (SICS) and <strong>Phacoemulsification</strong> are <strong>modern</strong> and <strong>efficient techniques for cataract surgery</strong>. These methods are indeed recommended for their safety, effectiveness, and relatively quick recovery times.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Both the Eyes Should Never be Operated at One Go</strong>: This is a <strong>standard guideline in eye care</strong>, especially in <strong>camp settings</strong>. Operating on both eyes simultaneously increases the risk of complications, including infection. Therefore, it is recommended to operate on one eye at a time.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Cases with Surgical Risks Such as Diabetes, Hypertensives &amp; Cardiac Problems Should Not be Operated in Camps</strong>: This statement is generally true. <strong>Patients with systemic conditions</strong> like <strong>diabetes</strong>, <strong>hypertension</strong>, or <strong>cardiac problems</strong> are at a <strong>higher risk of complications during and after surgery</strong>. Such cases typically require more comprehensive pre-operative and post-operative care than what might be available at an eye camp.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Recognize that the requirement of having at least 5 operating surgeons at eye camps is not a standardized guideline by the Government of India</strong>, unlike the recommendations for SICS &amp; Phacoemulsification techniques, the practice of not operating on both eyes simultaneously, and the avoidance of operating on high-risk patients in camp settings.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: pg 487/ systemic &amp; community ophthal/ AK KHURANA comprehensive ophthalmology / 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73931,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18494,
      "choices": [
        {
          "id": 73934,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Keplerian telescope</span></span></span></p>"
        },
        {
          "id": 73935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High plus spectacles</span></span></span></p>"
        },
        {
          "id": 73936,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Toric iol</span></span></span></p>"
        },
        {
          "id": 73937,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Video magnifier system</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a low vision aid (LVA)?</span></span></p>",
      "unique_key": "Q9084628",
      "question_audio": null,
      "question_video": null,
      "map_id": 18264,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Toric iol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low vision aids&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>optical devices used to improve the residual vision</strong> in <strong>visually handicapped individuals</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Eg: Hand held magnifiers</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Telescopes &ndash; Galilean, Kepler</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High plus spectacles</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Video magnifier systems</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;<strong>TORIC IOL</strong> are used to <strong>correct astigmatism</strong> along with <strong>cataract surgery</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/1-3.jpg\" style=\"height:265px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Keplerian Telescope</strong>: This is a <strong>type of telescopic device</strong> used as a <strong>low vision aid</strong>. It&#39;s designed to <strong>help people with low vision</strong> see <strong>objects at a distance</strong>, like street signs or bus numbers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/09/2-7.jpg\" style=\"height:158px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/picture23_P1QRsCS.jpg\" style=\"height:192px; width:250px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>High Plus Spectacles</strong>: These are <strong>spectacles</strong> with <strong>high magnification lenses</strong>. They are used as <strong>low vision aids</strong> to help <strong>people with poor vision to read or perform other close-up tasks</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/picture24_RSEzvTz.jpg\" style=\"height:250px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Video Magnifier System</strong>: This is a device that <strong>uses a camera to display enlarged images on a screen</strong>. It&#39;s a common low vision aid used for reading and viewing detailed objects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/picture25_21q0a7W.jpg\" style=\"height:300px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Recognize that TORIC IOLs</span></strong><span style=\"font-size:12.0pt\">, while used in <strong>eye surgery to correct astigmatism</strong>, are <strong>not classified as low vision aids</strong> (LVAs), unlike <strong>devices like Keplerian telescopes</strong>, <strong>high plus spectacles</strong>, and video magnifier systems that are specifically designed to assist those with low vision.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: pg 354/ theory and practise of optics and refraction/4<sup>th</sup> edition/ AK KHURANA</span></strong></span></span></p>",
      "correct_choice_id": 73936,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18495,
      "choices": [
        {
          "id": 73938,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">50%</span></span></span></p>"
        },
        {
          "id": 73939,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">30%</span></span></span></p>"
        },
        {
          "id": 73940,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0%</span></span></span></p>"
        },
        {
          "id": 73941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">60%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old man is blinded in one eye and the other eye is sighted. What is the percentage of disability in this man?</span></span></span></p>",
      "unique_key": "Q4580605",
      "question_audio": null,
      "question_video": null,
      "map_id": 18265,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 30%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/07/screenshot-2024-03-07-193048.jpg\" style=\"height:363px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><span style=\"font-size:12.0pt\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812759/\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812759/</strong></a><strong><u> </u>IJO</strong></span></span></span></p>",
      "correct_choice_id": 73939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18497,
      "choices": [
        {
          "id": 73946,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">30%</span></span></span></p>"
        },
        {
          "id": 73947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">50%</span></span></span></p>"
        },
        {
          "id": 73948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">90%</span></span></span></p>"
        },
        {
          "id": 73949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">100%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All those who are certified to have blindness by the appropriate authority as per the definitions given under the Rights of Persons with Disabilities Act, 2016 (49 of 2016), will be eligible to obtain an identity card. What should be the minimum percentage of disability that should be present?</span></span></span></p>",
      "unique_key": "Q2668417",
      "question_audio": null,
      "question_video": null,
      "map_id": 18271,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 90% </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As per the <strong>definitions given</strong> under the <strong>Rights of Persons with Disabilities Act, 2016</strong> (49 of 2016), <strong>percentage of blindness should be 90% or above</strong> to get a blind certificate.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/09/whatsapp-image-2023-06-12-at-1901210110102040.jpg\" style=\"height:496px; width:1000px\" /></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:</span></u></strong><strong> </strong><span style=\"font-size:12.0pt\"><a href=\"https://vikaspedia.in/education/parents-corner/guidelines-for-parents-of-children-with-disabilities/disability-certificate\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://vikaspedia.in/education/parents-corner/guidelines-for-parents-of-children-with-disabilities/disability-certificate</strong></a></span></span></span></p>",
      "correct_choice_id": 73948,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18498,
      "choices": [
        {
          "id": 73950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Railways</span></span></span></p>"
        },
        {
          "id": 73951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Income tax</span></span></span></p>"
        },
        {
          "id": 73952,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Children educational allowance</span></span></span></p>"
        },
        {
          "id": 73953,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Concessions given by the central &amp; the state governments for the disabled with the blind certificate include(s):</span></span></span></p>",
      "unique_key": "Q7468462",
      "question_audio": null,
      "question_video": null,
      "map_id": 18272,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Concessions&nbsp;</span></strong><span style=\"font-size:12.0pt\">given by the <strong>central &amp; the state governments</strong> for the <strong>disabled with the blind certificate</strong> include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Travel &amp; communications</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Customs</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Children&rsquo;s education allowance</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Income tax</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reservation of jobs</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Economic assistance</span></strong><span style=\"font-size:12.0pt\"> etc</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: </span></strong><span style=\"font-size:12.0pt\"><a href=\"http://www.rehabcouncil.nic.in/writereaddata/Appendices_5.pdf\" style=\"color:#0563c1; text-decoration:underline\"><strong>http://www.rehabcouncil.nic.in/writereaddata/Appendices_5.pdf</strong></a></span></span></span></p>",
      "correct_choice_id": 73953,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18506,
      "choices": [
        {
          "id": 73982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxypropyl methylcellulose </span></span></span></p>"
        },
        {
          "id": 73983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyaluronic acid </span></span></span></p>"
        },
        {
          "id": 73984,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium chloride </span></span></span></p>"
        },
        {
          "id": 73985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polyvinyl alcohol </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Use of all the following agents enhances the bioavailabiltity of drugs in the eye, except?</span></span></span></p>",
      "unique_key": "Q4053242",
      "question_audio": null,
      "question_video": null,
      "map_id": 18278,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Sodium chloride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Optino C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bioavailability of drug</span></strong><span style=\"font-size:12.0pt\"> in the eye is enhanced by <strong>use of viscous vehicles</strong> like: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxypropyl methyl cellulose </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polyvinyl alcohol </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polyvinyl pyrrolidone </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyaluronic acid </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Hydroxypropyl Methylcellulose (HPMC)</strong>: This is a <strong>viscoelastic polymer</strong> used as a <strong>viscosity-enhancing agent in eye drops</strong>. It increases the retention time of the drug on the eye&#39;s surface, thus enhancing bioavailability.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Hyaluronic Acid</strong>: Often used in <strong>ophthalmic formulations, hyaluronic acid has viscoelastic properties</strong> that can <strong>increase the contact time</strong> of the <strong>drug with the ocular surface</strong>, thereby enhancing drug absorption and bioavailability.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Polyvinyl Alcohol</strong>: This is <strong>another viscosity-enhancing agent</strong> used in <strong>ophthalmic preparations</strong>. It helps in prolonging the contact time of the drug on the ocular surface, thereby improving drug bioavailability.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sodium Chloride&nbsp;</span></strong><span style=\"font-size:12.0pt\">is used for <strong>tonicity adjustment in ophthalmic solutions.</strong> It <strong>does not enhance the bioavailability of drugs in the eye</strong>, unlike <strong>viscosity-enhancing agents like Hydroxypropyl Methylcellulose</strong>, Hyaluronic Acid, and Polyvinyl Alcohol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 146</span></strong></span></span></p>",
      "correct_choice_id": 73984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18508,
      "choices": [
        {
          "id": 73990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.1% Dexamethasone acetate </span></span></span></p>"
        },
        {
          "id": 73991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.1% Fluorometholone </span></span></span></p>"
        },
        {
          "id": 73992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1% Medroxyprogesterone&nbsp; </span></span></span></p>"
        },
        {
          "id": 73993,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1% Prednisolone acetate </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following solutions has the greatest anti-inflammatory action?</span></span></span></p>",
      "unique_key": "Q8800075",
      "question_audio": null,
      "question_video": null,
      "map_id": 18279,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) 1% Prednisolone acetate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The anti-inflammatory action of steroids</span></strong><span style=\"font-size:12.0pt\"> &ndash; from <strong>high to low</strong>:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topical ophthalmic steroids placed in descending order of potency:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Difluprednate ophthalmic emulsion 0.05%w/v(most potent)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prednisolone Acetate 1% </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dexamethasone 0.1%</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Betamethasone 0.1%</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prednisolone Sodium Phosphate 0.5%</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluorometholone 0.1% (least potent)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>0.1% Dexamethasone Acetate</strong>: <strong>Dexamethasone</strong> is a <strong>potent corticosteroid</strong>. It is <strong>highly effective in reducing inflammation</strong> and is <strong>commonly used in ophthalmology</strong> for its strong anti-inflammatory properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>0.1% Fluorometholone</strong>: <strong>Fluorometholone is less potent</strong> compared to <strong>dexamethasone</strong> and <strong>prednisolone</strong>. It is often <strong>used for inflammatory conditions</strong> of the <strong>eye</strong> where the risk of steroid-induced intraocular pressure (IOP) increase is a concern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>1% Medroxyprogesterone</strong>: This is a <strong>synthetic progestin</strong> and is <strong>not typically known for strong anti-inflammatory effects</strong> in ophthalmic use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understand that <strong>1% Prednisolone Acetate</strong>, due to its <strong>high potency and concentration</strong>, is likely the <strong>most effective</strong> among the listed options for providing <strong>strong anti-inflammatory action in ophthalmic use</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION page 154</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. </span></strong><span style=\"font-size:12.0pt\"><a href=\"https://www.formularywkccgmtw.co.uk/therapeutic-sections/eye/inflammatory-eye-conditions/corticosteroids-and-the-eye/\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.formularywkccgmtw.co.uk/therapeutic-sections/eye/inflammatory-eye-conditions/corticosteroids-and-the-eye/</strong></a></span></span></span></p>",
      "correct_choice_id": 73993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18512,
      "choices": [
        {
          "id": 74006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Timolol </span></span></span></p>"
        },
        {
          "id": 74007,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carteolol </span></span></span></p>"
        },
        {
          "id": 74008,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Levobunolol</span></span></span></p>"
        },
        {
          "id": 74009,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Betaxolol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following beta blockers is known to increase the perfusion of optic nerve head? </span></span></span></p>",
      "unique_key": "Q2452691",
      "question_audio": null,
      "question_video": null,
      "map_id": 18282,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Betaxolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Betaxolol is the only beta-1 specific beta blocker</span></strong><span style=\"font-size:12.0pt\">.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is believed to <strong>increase the perfusion of the optic nerve head</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Confers neuroprotection.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is associated with <strong>fewer pulmonary side effects.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Timolol</strong>: A <strong>non-selective beta blocker</strong> widely used in the <strong>treatment of glaucoma</strong>. While <strong>effective in lowering intraocular pressure</strong>, it does not have a significant effect on increasing optic nerve head perfusion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Carteolol</strong>: Another <strong>non-selective beta blocker</strong> with <strong>intrinsic sympathomimetic activity</strong>. It lowers intraocular pressure but does not specifically increase optic nerve head perfusion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>Levobunolol</strong>: Similar to <strong>Timolol</strong>, <strong>Levobunolol is a non-selective beta blocker used for lowering intraocular pressure</strong>. It is not known to significantly affect optic nerve head perfusion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Due to its beta &ndash; 1 blocker selectivity</span></strong><span style=\"font-size:12.0pt\">, <strong>Betaxolol</strong> has a <strong>lesser effect on pulmonary and vascular beta-2 receptors.</strong> It is known to <strong>potentially increase blood flow</strong> to the <strong>optic nerve head,</strong> which could be beneficial in glaucoma patients where optic nerve head perfusion is a concern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 157</span></strong></span></span></p>",
      "correct_choice_id": 74009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18513,
      "choices": [
        {
          "id": 74010,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Povidone</span></span></span></p>"
        },
        {
          "id": 74011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chlorobutanol</span></span></span></p>"
        },
        {
          "id": 74012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benzalkonium chloride</span></span></span></p>"
        },
        {
          "id": 74013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium perborate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following preservatives is the most epitheliotoxic? </span></span></span></p>",
      "unique_key": "Q7925169",
      "question_audio": null,
      "question_video": null,
      "map_id": 18283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Benzalkonium chloride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Opiton C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Preservatives&nbsp;</span></strong><span style=\"font-size:12.0pt\">in <strong>standard commercial preparations</strong> are <strong>epitheliotoxic to the cornea</strong> and <strong>conjunctiva</strong> if used very frequently.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;<strong>Benzalkonium chloride&nbsp;</strong>is the most <strong>epitheliotoxic.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Povidone&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Chlorobutanol</strong> are <strong>better tolerated.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Some newer preservatives such as sodium perborate and purite disintegrate into harmless molecules on contact with the eye and exposure to light.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Povidone</strong>: Often used as a <strong>lubricant in artificial tears</strong>, <strong>povidone is generally gentle on the epithelial cells of the eye</strong>. It&#39;s less likely to cause irritation or damage to the surface of the eye compared to some other preservatives.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Chlorobutanol</strong>: This <strong>preservative</strong> is known for its<strong> mildness and is less irritating to the ocular surface.</strong> However, it is less commonly used due to its limited antimicrobial efficacy and stability issues in certain formulations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Sodium Perborate</strong>: This is a <strong>preservative that decomposes into water and oxygen</strong> upon <strong>contact with the eye</strong>, making it much gentler on the epithelial cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Benalkonium Chloride&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the more <strong>epitheliotoxic preservative agent</strong>. This is a <strong>common preservative in ophthalmic solutions</strong> but is known for its <strong>cytotoxic effects on the corneal and conjunctival epithelial cells</strong>. It can disrupt the tear film and cause ocular surface disease with long-term use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: PARSONS DISEASES OF THE EYE PAGE 158</span></strong></span></span></p>",
      "correct_choice_id": 74012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}